ESMO Preceptorship on Hereditary Cancer Genetics Banner

Start date: 26 Apr 2019
End date: 27 Apr 2019
Location: Lugano, Switzerland

Learning objectives

To learn about the best clinical practice in the multidisciplinary management of hereditary cancer syndromes
To understand the molecular basis and heterogeneity of the genetic susceptibility to develop cancer
To learn how to recognize, diagnose, treat and provide prevention recommendations to patients with a germline genetic susceptibility

Accreditation

The programme of this event has been accredited with 10 ESMO-MORA Cat. 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further information please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

Judith Balmaña, Spain
Nicoline Hoogerbrugge, Netherlands